Explore evidence

29 décèsEntre janvier et juillet 2018, 29 décès liés au paludisme ont été enregistrés à Bafia.

Camerounpaludismeobserved janvier et juillet 2018HAL · Unilimdocument of 67 observations

29.4 daysThe highest duration of hospitalization was recorded in patients with foot problems (29.4+/-5.4 days).

Camerounpied diabétiqueobserved November 1999 to October 2000published 2006The international journal of lower extremity woundseurope_pmcdocument of 6 observations

15.6 %Among patients with type 2 diabetes, the proportion with proteinuria was 15.6% in wave 1, 9.3% in wave 3, and 7.6% in wave 7.

Cameroundiabète de type 2 · proteinuriapublished 2021Diabetologiaeurope_pmcdocument of 14 observations

5.5 %Diabetes prevalence in 2021 was estimated to be 5.5% in low-income countries.

Cameroundiabète (non précisé)observed 2021published 2022Diabetes research and clinical practiceeurope_pmcdocument of 7 observationsDOI 10.1016/j.diabres.2021.109119

2.5 odds_ratioThe odds ratio for tuberculosis risk in cross-sectional studies with diabetes mellitus was 2.5 with a 95% confidence interval of [1.8–3.5].

Cameroundiabète (non précisé) · tuberculosepublished 2021PloS oneeurope_pmcdocument of 10 observationsDOI 10.1371/journal.pone.0261246

-0.59 SMDHIV infection was associated with lower high-density lipoprotein with a standardized mean difference of -0.59.

Camerounhigh-density lipoprotein · VIH/sidapublished 2013International journal of epidemiologyeurope_pmcdocument of 10 observationsDOI 10.1093/ije/dyt198

142 isolatesAmong 142 HIV-1 isolates from antiretroviral-naive patients, 4 belonged to group O and 138 belonged to group M.

CamerounVIH/sidapublished 2000Journal of Clinical MicrobiologyOpenAlexdocument of 19 observations

38 hazard_ratioProgressive hyperglycemia is a strong risk factor for ketotic relapses in ketosis-prone type 2 diabetes, with a hazard ratio of 38.

Cameroundiabète de type 2published 2004Diabeteseurope_pmcdocument of 8 observationsDOI 10.2337/diabetes.53.3.645

50.9 %Among the 173 diabetic participants, 88 (50.9%) were positive for HHV8 antibodies.

Cameroundiabète (non précisé) · HHV8published 2018Journal of diabeteseurope_pmcdocument of 10 observations

0.25 %Foot problems accounted for 0.25% of bed occupancy for the selected period.

Camerounpied diabétiqueobserved November 1999 to October 2000published 2006The international journal of lower extremity woundseurope_pmcdocument of 6 observations

13.6 %Using the standard examination method, the prevalence of diabetic retinopathy was 13.6%.

Cameroundiabetic retinopathypublished 2019Ophthalmic surgery, lasers & imaging retinaeurope_pmcdocument of 16 observations

86 %In 2002, 86 percent of global cardiovascular disease (CVD) mortality and morbidity occurred in developing countries.

Camerounmaladies cardiovasculairesobserved 2002published 2006Cardiovascular Diseaseeurope_pmcdocument of 5 observations

22.8 %The mean global lifetime risk of stroke increased from 22.8% in 1990 to 24.9% in 2016.

CamerounAVCobserved 1990published 2018The New England journal of medicineeurope_pmcdocument of 12 observations

53.1 %Microalbuminuria was detected in 53.1% of 64 non-proteinuric diabetic patients in Cameroon.

Camerounmicroalbuminuriapublished 1999Diabetes research and clinical practiceeurope_pmcdocument of 2 observations

0.39 SMDAmong HIV+ individuals, antiretroviral therapy use was associated with higher high-density lipoprotein with a standardized mean difference of 0.39.

Camerounhigh-density lipoprotein · VIH/sidapublished 2013International journal of epidemiologyeurope_pmcdocument of 10 observationsDOI 10.1093/ije/dyt198

49.6 %La prévalence de la neuropathie chez les personnes atteintes d'hépatite au Cameroun était de 49,6 % en 2018.

Camerounhépatiteobserved 2018HAL · Unilimdocument of 747 observations

20 %In 2010, 20% of 40 ART sites in Cameroon attained the target for patient retention on first line ART (target ≥ 70%).

CamerounVIH/sidaobserved 2010published 2012PLoS ONEOpenAlexdocument of 5 observationsDOI 10.1371/journal.pone.0036777

4.3 %Global age-standardised diabetes prevalence increased from 4.3% in 1980 to 9.0% in 2014 in men.

Cameroundiabète (non précisé)observed 1980published 2016Lancet (London, England)europe_pmcdocument of 7 observationsDOI 10.1016/s0140-6736(16)00618-8

7.4 yearsThe mean duration of diabetes is 7.4±6.3 years among enrolled patients.

Cameroundiabète (non précisé)published 2017The Pan African medical journaleurope_pmcdocument of 7 observations

43 per_1000Le nombre de décès dus au paludisme confirmés pour 1000 personnes par an, chez les patients hospitalisés, était de 43 pour mille en 2013.

Camerounpaludismeobserved 2013HAL · Unilimdocument of 98 observations

24.3 %Le paludisme est la première cause de consultations (24,3 %) dans les formations sanitaires au Cameroun.

CamerounpaludismeHAL · Unilimdocument of 67 observations

25.9 %Among patients with type 2 diabetes (T2D), 25.9% cited lack of support as a reason for insulin discontinuation.

Cameroundiabète de type 2observed 2016-2017published 2021Advances in therapyeurope_pmcdocument of 12 observations

93 %The T allele frequency of the rs7903146 (C/T) polymorphism of the TCF7L2 gene was 93% in the study population.

Camerounobésitépublished 2017Journal of health, population, and nutritioneurope_pmcdocument of 3 observations

50 %Cardiomyopathy may affect up to 50% of all diabetic patients in sub-Saharan Africa.

Camerouncardiomyopathy · diabète (non précisé)published 2005Circulationeurope_pmcdocument of 5 observationsDOI 10.1161/circulationaha.105.544312

79 bpm24-h mean heart rate was 79 bpm in the poorly controlled type 2 diabetes group.

Cameroundiabète de type 2published 2018BMC research noteseurope_pmcdocument of 8 observations